Early Phase 1 Breast Cancer Trial, Recruiting NCT06586047 Sponsor: Ahmad Shariftabrizi Condition: Breast Cancer
Back to Breast Cancer

Early Phase 1 Breast Cancer Trial, Recruiting

NCT06586047
Recruiting Early Phase 1

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • Women aged 18 or older
  • People diagnosed with triple-negative breast cancer (TNBC) that has spread to distant parts of the body, confirmed by an initial biopsy
  • People whose cancer lesions show up as active (FDG positive) on the PET/CT scan performed as part of this study

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who have another type of cancer that is currently active
  • People who are unable to tolerate or complete a PET/CT scan procedure
  • People who are pregnant or breastfeeding
  • People who have a medical condition that could make it unsafe to undergo PET scan imaging (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 July 2026
Early Phase 1 studies are small, early exploratory studies that come before the main Phase 1 to 3 testing, so a standard phase success rate does not apply.

Contact this trial

Phone: 319-887-4942

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Early Phase 1
Sponsor
Ahmad Shariftabrizi
Registry
ClinicalTrials.gov
Start date
29 August 2024
Est. completion
29 December 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Lesion detection sensitivity analysis

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov